# A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors

> **NCT06328439** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Avistone Biotechnology Co., Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Locally Advanced or Metastatic Solid Tumors

## Interventions

- **DRUG:** ANS014004

## Key facts

- **NCT ID:** NCT06328439
- **Lead sponsor:** Avistone Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-05-19
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-01-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-03-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06328439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06328439, "A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT06328439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*